Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprative Study of the Safety and Effectiveness Between Oculusgen (Ologen) Collagen Matrix Implant and Mitomycin-C in Glaucoma Filtering Surgery

NCT00524758 is registered in ClinicalTrials.gov with Pro Top & Mediking Company Limited as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprative Study of the Safety and Effectiveness Between Oculusgen (Ologen) Collagen Matrix Implant and Mitomycin-C in Glaucoma Filtering Surgery
Lead sponsor
Pro Top & Mediking Company Limited
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2007
Completion date
October 31, 2011
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angle closure glaucoma, high risk patient, neovascular glaucoma, open angle glaucoma, uveitis glaucoma, young age glaucoma